{
  "actions": [
    {
      "acted_at": "2011-04-12",
      "action_code": "Intro-H",
      "references": [],
      "text": "Introduced in House",
      "type": "action"
    },
    {
      "acted_at": "2011-04-12",
      "action_code": "H11100",
      "committees": [
        "HSIF"
      ],
      "references": [],
      "status": "REFERRED",
      "text": "Referred to the House Committee on Energy and Commerce.",
      "type": "referral"
    },
    {
      "acted_at": "2011-04-15",
      "action_code": "",
      "committees": [
        "HSIF"
      ],
      "references": [],
      "text": "Referred to the Subcommittee on Health.",
      "type": "referral"
    }
  ],
  "amendments": [],
  "bill_id": "hr1483-112",
  "bill_type": "hr",
  "by_request": false,
  "committee_reports": [],
  "committees": [
    {
      "activity": [
        "referral"
      ],
      "committee": "House Energy and Commerce",
      "committee_id": "HSIF"
    },
    {
      "activity": [
        "referral"
      ],
      "committee": "House Energy and Commerce",
      "committee_id": "HSIF",
      "subcommittee": "Subcommittee on Health",
      "subcommittee_id": "14"
    }
  ],
  "congress": "112",
  "cosponsors": [
    {
      "bioguide_id": "A000022",
      "district": "5",
      "name": "Ackerman, Gary L.",
      "original_cosponsor": false,
      "sponsored_at": "2012-02-01",
      "state": "NY",
      "title": "Rep.",
      "withdrawn_at": null
    },
    {
      "bioguide_id": "C001036",
      "district": "23",
      "name": "Capps, Lois",
      "original_cosponsor": false,
      "sponsored_at": "2011-04-14",
      "state": "CA",
      "title": "Rep.",
      "withdrawn_at": null
    },
    {
      "bioguide_id": "C001085",
      "district": "13",
      "name": "Clarke, Hansen",
      "original_cosponsor": false,
      "sponsored_at": "2011-04-14",
      "state": "MI",
      "title": "Rep.",
      "withdrawn_at": null
    },
    {
      "bioguide_id": "D000197",
      "district": "1",
      "name": "DeGette, Diana",
      "original_cosponsor": true,
      "sponsored_at": "2011-04-12",
      "state": "CO",
      "title": "Rep.",
      "withdrawn_at": null
    },
    {
      "bioguide_id": "J000283",
      "district": "2",
      "name": "Jackson, Jesse L., Jr.",
      "original_cosponsor": false,
      "sponsored_at": "2011-09-07",
      "state": "IL",
      "title": "Rep.",
      "withdrawn_at": null
    },
    {
      "bioguide_id": "K000009",
      "district": "9",
      "name": "Kaptur, Marcy",
      "original_cosponsor": false,
      "sponsored_at": "2012-03-22",
      "state": "OH",
      "title": "Rep.",
      "withdrawn_at": null
    },
    {
      "bioguide_id": "L000551",
      "district": "9",
      "name": "Lee, Barbara",
      "original_cosponsor": false,
      "sponsored_at": "2012-03-05",
      "state": "CA",
      "title": "Rep.",
      "withdrawn_at": null
    },
    {
      "bioguide_id": "M000312",
      "district": "3",
      "name": "McGovern, James P.",
      "original_cosponsor": false,
      "sponsored_at": "2011-04-14",
      "state": "MA",
      "title": "Rep.",
      "withdrawn_at": null
    },
    {
      "bioguide_id": "N000147",
      "district": "0",
      "name": "Norton, Eleanor Holmes",
      "original_cosponsor": false,
      "sponsored_at": "2012-02-17",
      "state": "DC",
      "title": "Del.",
      "withdrawn_at": null
    },
    {
      "bioguide_id": "P000034",
      "district": "6",
      "name": "Pallone, Frank, Jr.",
      "original_cosponsor": true,
      "sponsored_at": "2011-04-12",
      "state": "NJ",
      "title": "Rep.",
      "withdrawn_at": null
    },
    {
      "bioguide_id": "R000515",
      "district": "1",
      "name": "Rush, Bobby L.",
      "original_cosponsor": false,
      "sponsored_at": "2011-09-07",
      "state": "IL",
      "title": "Rep.",
      "withdrawn_at": null
    },
    {
      "bioguide_id": "S000480",
      "district": "28",
      "name": "Slaughter, Louise McIntosh",
      "original_cosponsor": false,
      "sponsored_at": "2011-05-02",
      "state": "NY",
      "title": "Rep.",
      "withdrawn_at": null
    },
    {
      "bioguide_id": "S001175",
      "district": "12",
      "name": "Speier, Jackie",
      "original_cosponsor": false,
      "sponsored_at": "2011-07-07",
      "state": "CA",
      "title": "Rep.",
      "withdrawn_at": null
    },
    {
      "bioguide_id": "S000810",
      "district": "13",
      "name": "Stark, Fortney Pete",
      "original_cosponsor": false,
      "sponsored_at": "2011-05-05",
      "state": "CA",
      "title": "Rep.",
      "withdrawn_at": null
    },
    {
      "bioguide_id": "W000215",
      "district": "30",
      "name": "Waxman, Henry A.",
      "original_cosponsor": true,
      "sponsored_at": "2011-04-12",
      "state": "CA",
      "title": "Rep.",
      "withdrawn_at": null
    }
  ],
  "enacted_as": null,
  "history": {
    "active": false,
    "awaiting_signature": false,
    "enacted": false,
    "vetoed": false
  },
  "introduced_at": "2011-04-12",
  "number": "1483",
  "official_title": "To amend the Federal Food, Drug, and Cosmetic Act to improve the safety of drugs, and for other purposes.",
  "popular_title": null,
  "related_bills": [],
  "short_title": "Drug Safety Enhancement Act of 2011",
  "sponsor": {
    "bioguide_id": "D000355",
    "district": "15",
    "name": "Dingell, John D.",
    "state": "MI",
    "title": "Rep.",
    "type": "person"
  },
  "status": "REFERRED",
  "status_at": "2011-04-12",
  "subjects": [
    "Administrative law and regulatory procedures",
    "Administrative remedies",
    "Business records",
    "Civil actions and liability",
    "Criminal procedure and sentencing",
    "Department of Health and Human Services",
    "Drug safety, medical device, and laboratory regulation",
    "Employment discrimination and employee rights",
    "Evidence and witnesses",
    "Executive agency funding and structure",
    "Government information and archives",
    "Government studies and investigations",
    "Health",
    "Jurisdiction and venue",
    "Licensing and registrations",
    "Manufacturing",
    "Trade restrictions",
    "User charges and fees"
  ],
  "subjects_top_term": "Health",
  "summary": {
    "as": "Introduced in House",
    "asOf": "2011-04-12",
    "date": "2011-06-21T20:23:32Z",
    "text": "Drug Safety Enhancement Act of 2011 - Amends the Federal Food, Drug, and Cosmetic Act (FFDCA) to expand drug establishment registration requirements to include foreign drug establishments and establishments manufacturing, preparing, propagating, compounding, or processing excipients of drugs (i.e., inactive drug additives). Requires the Secretary of Health and Human Services (HHS) to collect registration fees.\n\nRequires drug manufacturers to: (1) implement an effective quality system that requires compliance with current good manufacturing practices and timely communication of product quality issues; (2) establish risk management procedures that ensure effective risk assessment, control, and communication; and (3) establish procedures that ensure the safety, identity, quality, strength, purity, and security of all drugs and other materials used by the manufacturer.\n\nRequires drug establishments to maintain records on the supply chain of the drug, ingredients, and raw materials.\n\nEstablishes the frequency of inspections of drug establishments. Prohibits delaying or limiting an inspection.\n\nGives the Secretary authority to order the recall of, detain, destroy, and seize drugs as necessary.\n\nEstablishes civil and criminal penalties for violations of FFDCA provisions.\n\nAuthorizes the Secretary to require documentation of an imported drug and refuse admission if such documentation is not provided.\n\nRequires the Secretary to: (1) require drug importers to register and to comply with good importer practices, (2) require a customs broker with respect to drugs to register, and (3) establish a corps of inspectors dedicated to inspections of foreign drug facilities and establishments.\n\nRequires drug establishments, importers, and customs brokers to have a unique identifier.\n\n Deems a finished dosage form drug to be misbranded if the manufacturer's website does not list country of origin labeling for each active pharmaceutical ingredient and the place of manufacture of the finished dosage form of such drug.\n\nGives the Commissioner of the Food and Drug Administration (FDA) subpoena authority.\n\nEstablishes whistleblower protections."
  },
  "titles": [
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "Drug Safety Enhancement Act of 2011",
      "type": "short"
    },
    {
      "as": null,
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "Drug Safety Enhancement Act of 2011",
      "type": "display"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "To amend the Federal Food, Drug, and Cosmetic Act to improve the safety of drugs, and for other purposes.",
      "type": "official"
    }
  ],
  "updated_at": "2021-04-19T18:32:05Z",
  "url": "https://www.govinfo.gov/bulkdata/BILLSTATUS/112/hr/BILLSTATUS-112hr1483.xml"
}